The pathophysiological mechanisms involved in fibrotic interstitial lung diseases (FILDs) are
akin to those observed in idiopathic pulmonary fibrosis (IPF), implying the potential for …

Objective Patients with lung cancer with underlying idiopathic pulmonary fibrosis and usual
interstitial pneumonia (UIP) pattern on CT represent a very high-risk group in terms of …

Dermatomyositis (DM) is associated with interstitial lung disease (ILD) and malignancy.
However, the coexistence of ILD and malignancy (DM–ILD–malignancy) is rare, and limited …

Background Acute exacerbation of idiopathic interstitial pneumonias (AE-IIPs) induces
permanent pulmonary dysfunction and is potentially lethal. The unpredictable occurrence of …

In this study, we aimed to investigate the feasibility of serum Krebs von den Lungen-6 (KL-6)
as a potential biomarker for treatment-related ILD (TR-ILD) in lung cancer. We recruited …

Background Patients with interstitial lung disease (ILD) may have a poor prognosis after
lung cancer surgery because of respiratory complications and increased recurrence rates …

Background Acute exacerbation (AE) of interstitial lung disease (ILD) is one of the most
serious complications during perioperative period of lung cancer resection. This study aimed …

Objective Lobectomy is the standard treatment for patients with early-stage non–small cell
lung cancer (NSCLC). In recent years, an increasing number of patients with lung cancer …

Abstract Background and Objective The lung immune prognostic index (LIPI), a simple index
calculated from the blood lactate dehydrogenase level and derived neutrophil‐to …

Résumé La concomitance d'un cancer bronchique et d'une pneumopathie interstitielle
diffuse (PID) fibrosante n'est ni fortuite ni exceptionnelle. Les modalités diagnostiques et …